Article info
PDFOvarian cancer
418 First real-world hematologic adverse events experience with niraparib in advanced ovarian cancer
Citation
418 First real-world hematologic adverse events experience with niraparib in advanced ovarian cancer
Publication history
- First published December 4, 2020.
Online issue publication
February 04, 2021
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.